ubrogepant(Ubrelvy)
CGRP receptor antagonist (gepant)
Pronunciation
/juːˈbroʊɡəpænt/
International Phonetic Alphabet (IPA). Say it aloud once — you will remember it forever.
At a glance
- Generic name
- ubrogepant
- Brand names
- Ubrelvy
- Therapeutic class
- CGRP receptor antagonist (gepant)
- Mechanism (summary)
- <!-- AI-DRAFTED: 2026-06-24 -->
Clinical pearls
- Take at onset of migraine; may repeat in 2h if needed (max 200 mg/24h).
- No vasoconstriction - safe in CV disease (unlike triptans).
- Acute treatment only - not for prevention (use rimegepant or CGRP mAb).
- Report rash or breathing difficulty.
- ### NAPLEX practice notes
Sources
See how ubrogepant appears in NAPLEX-style questions
PharmDHub Premium includes a full drug card, dosing, boxed warnings, drug-drug interactions, and practice questions built around this drug.